pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›calendar
  3. ›phase readout
phase readout
save

NCT06627764: SER Familia: A Family-Based Intervention Addressing Syndemic Conditions Among Latino Immigrant Families

RECRUITINGupdated 5mo ago
community read0 votes

Sponsor: Duke University. Phase: NA. Conditions: Substance Abuse, Intimate Partner Violence (IPV), HIV Infections, Depression, Anxiety

view source ↗
Data sources
ctgov
last refreshed 5h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

same company · ±60 days · 6

  • phase 1 2 completiondeferiprone: Duke University — deferiprone (Phase I/II Trial Completion)Apr 30, 2026
  • grantDUKE UNIVERSITY — Mentoring in Anti-Infective Clinical Pharmacology and PharmacometricsApr 3, 2026
  • grantDUKE UNIVERSITY — Modulation of HIV immune control by HLA-E-VL9 and HLA-E-VL9 binding antibodiesApr 1, 2026
  • grantDUKE UNIVERSITY — A gut sense for dietary lysineApr 1, 2026
  • grantDUKE UNIVERSITY — Cell signaling through O-linked glycosylationApr 1, 2026
  • grantDUKE UNIVERSITY — Defining the mechanisms of Epstein-Barr virus persistence and recurrenceApr 1, 2026

related news · 8

  • statOpinion: Former FDA commissioners: Heidi Overton has an opportunity to strengthen the FDA↗
  • statSTAT+: ARPA-H to invest $62 million to develop FDA-authorized AI to help treat heart failure↗
  • biospaceLilly joins Novo in cardiovascular space after FDA nod for GLP-1/GIP agonist Mounjaro↗
  • fiercebiotechEvaxion scraps solid tumor vaccine to focus on Duke-partnered brain cancer candidate↗
  • fiercebiotechChutes & Ladders—Biogen R&D vet gets in Formation↗
  • statAs Maui recovers from devastating fires, a study offers vision for new rural health model↗
  • statTiny HHS office tasked with protecting research participants’ safety is running on fumes↗
  • statTop ultra-processed food researchers call for sweeping policy change: ‘The system is rigged’↗

🐶 often sniffed alongside

top 8
  • tagImmunology4 co-mentions · 4 sources
  • tagOncology3 co-mentions · 3 sources
  • tagPulmonology2 co-mentions · 2 sources
  • tagAlzheimer's Disease2 co-mentions · 2 sources
  • tagEndocrinology & Metabolism2 co-mentions · 2 sources
  • tagNephrology1 co-mentions · 1 sources
  • tagInfectious Disease1 co-mentions · 1 sources
  • tagCardiology1 co-mentions · 1 sources

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?